查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1781946

人体微生物组市场，按产品、按疾病、按类型、按给药途径、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Human Microbiome Market, By Product, By Diseases, By Type, By Route of Administration, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年人类微生物组市场规模价值 8.219 亿美元，2025 年至 2032 年的复合年增长率为 31.20%。

人类微生物组市场-市场动态

慢性病盛行率上升推动市场需求

肥胖、糖尿病和发炎性肠道疾病 (IBD) 等慢性疾病的发病率不断上升，推动了对基于微生物组的疗法的需求。根据《2023 年世界肥胖地图集》，全球约 31.2 亿人（占人口的 38%）超重或肥胖。此外，大量的政府资金投入正在加速微生物组科学的进步，从而推动全球人类微生物组市场的成长。然而，高昂的研发成本和严格的监管框架可能会在预测期内阻碍市场成长。相反，对个人化医疗保健的日益重视为基于微生物组的诊断和针对个别微生物组特征的治疗提供了机会。

人类微生物组市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 31.20%

根据产品细分，益生菌预计在 2024 年占据最大市场份额

根据疾病细分，胃肠道疾病是 2024 年的主要疾病

根据类型细分，活体生物治疗产品 (LBP) 是 2024 年的主要类型

按地区划分，北美是 2024 年的主要收入来源

人类微生物组市场-細項分析：

全球人类微生物组市场根据产品、疾病、类型、给药途径、最终用户和地区进行细分。

根据产品类型，市场分为四大类：益生元、益生菌、药物和共生元。预计在预测期内，益生菌将在全球人类微生物组市场中占据最大份额。这种主导地位的形成归因于消费者对益生菌对肠道健康、免疫力和整体健康的益处的认识不断提高。

依疾病类型，市场可分为四类：胃肠道疾病、传染病、内分泌及代谢性紊乱等疾病。其中，胃肠道疾病预计将占据最大的市场份额。这种主导地位归因于肠躁症 (IBS)、发炎性肠道疾病 (IBD)、乳糜泻和胃食道逆流症 (GERD) 等胃肠道疾病的盛行率较高。

人类微生物组市场—地理洞察

北美地区占据全球人类微生物组市场的最大份额。这种优势归功于其完善的医疗基础设施、对微生物组研究的大量投入以及慢性病的高发病率。此外，预计亚太地区在预测期内将经历人类微生物组市场最快的成长。这项快速扩张的驱动力源于人们对微生物组健康的认识不断提高、个人化医疗需求的不断增长以及测序技术的进步。

人类微生物组市场-竞争格局：

人们对个人化医疗和基于微生物组的疗法日益增长的兴趣，正推动这一新兴领域的企业之间展开激烈竞争。产业参与者正致力于与研究机构和医疗保健提供者建立策略合作，以加速产品开发。许多公司正在大力投资研发，以发现基于微生物组的新型诊断方法和治疗方法。此外，各公司正在申请专利并签订授权协议，以增强其产品线。向尚未开发的地区扩张以及开发以消费者为导向的微生物组产品也是关键的竞争策略。

最新动态：

2025 年 2 月，Seres Therapeutics 推出了 SER-109，这是美国首个获得 FDA 批准的微生物组疗法，旨在透过使用活细菌孢子恢復肠道菌群来治疗復发性艰难梭菌感染。

目录

第一章：人类微生物组市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 人类微生物组市场（按产品）片段
    • 人类微生物组市场（按疾病）
    • 人类微生物组市场片段（按类型）
    • 人类微生物组市场依给药途径划分
    • 人类微生物组市场片段（按最终用户）
    • 人类微生物组市场（按国家/地区）
    • 人类微生物组市场（按地区）
  • 竞争洞察

第三章：人类微生物组关键市场趋势

  • 人类微生物组市场驱动因素
    • 市场驱动因素的影响分析
  • 人类微生物组市场限制
    • 市场限制的影响分析
  • 人类微生物组市场机会
  • 人类微生物组市场未来趋势

第四章：人类微生物组产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：人类微生物组市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：人类微生物组市场模式

  • 2024年人类微生物组市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：人体微生物组市场－依产品

  • 概述
    • 按产品细分的市占率分析
    • 益生菌
    • 药物
    • 合生元

第 8 章：人类微生物组市场 - 按疾病

  • 概述
    • 按疾病细分的份额分析
    • 胃肠道疾病
    • 传染病
    • 内分泌与代谢紊乱
    • 其他疾病

第九章：人体微生物组市场－依类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 活体生物治疗产品（LBP）
    • 细菌合併移植（BCT）/粪便微生物移植（FMT）
    • 其他微生物组类型

第 10 章：人体微生物组市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 直肠
    • 口服

第 11 章：人类微生物组市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 长期照护机构
    • 医院和诊所
    • 其他的

第 12 章：人类微生物组市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美人体微生物组主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品）
    • 北美市场规模及预测（依疾病分类）
    • 北美市场规模和预测（按类型）
    • 北美市场规模及预测（按给药途径）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲人体微生物组主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模及预测（依疾病分类）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模及预测（依管理途径）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区人体微生物组主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品）
    • 亚太地区市场规模及预测（依疾病分类）
    • 亚太地区市场规模及预测（按类型）
    • 亚太地区市场规模及预测（依管理途径）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲人体微生物组主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品）
    • 拉丁美洲市场规模及预测（依疾病分类）
    • 拉丁美洲市场规模及预测（按类型）
    • 拉丁美洲市场规模及预测（依管理途径）
    • LATAM 规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲人体微生物组主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（依疾病分类）
    • 中东和非洲市场规模和预测（按类型）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：关键供应商分析-人类微生物组产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • ENTEROME
    • Pendulum
    • DuPont
    • Yakult USA Inc.
    • Metabiomics
    • Vedanta Biosciences, Inc.
    • Optibiotix Health plc
    • Microbiome Therapeutics Innovation Group
    • BioHM Health
    • Osel, Inc.
    • Seres Therapeutics
    • Infinant Health Inc.
    • Merck & Co., Inc.
    • Theriva Biologics
    • Qualigen Therapeutics, Inc.
    • Synlogic
    • Symbiotix, LLC
    • Resbiotic
    • Symberix, Inc.
    • Exegi Pharma Inc.
    • Seed Health Inc.
    • Biogaia AB
    • BiomeBank
    • Ferring Pharmaceuticals
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5432

REPORT HIGHLIGHT

Human microbiome market size was valued at US$ 821.90 Million in 2024, expanding at a CAGR of 31.20% from 2025 to 2032.

The human microbiome refers to the diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body such as the gut, skin, mouth, and respiratory tract. These microorganisms play a vital role in maintaining health by aiding digestion, supporting the immune system, and protecting against pathogens. Disruptions in the microbiome balance are linked to various diseases, including obesity, diabetes, and autoimmune disorders.

Human Microbiome Market- Market Dynamics

Increasing prevalence of chronic diseases to propel market demand

The increasing incidence of chronic conditions such as obesity, diabetes, and inflammatory bowel disease (IBD) is propelling the demand for microbiome-based therapies. According to the World Obesity Atlas 2023, 38% of the global population, approximately 3.12 billion people are overweight or obese. In addition, substantial government funding is accelerating advancements in microbiome science, which is driving the growth of the global human microbiome market. However, high cost of R&D and stringent regulatory frameworks may hamper the market growth during the forecast period. On the contrary, the growing emphasis on personalized healthcare presents opportunities for microbiome-based diagnostics and treatments tailored to individual microbiota profiles.

Human Microbiome Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 31.20% over the forecast period (2025-2032)

Based on Product segmentation, probiotics was predicted to show maximum market share in the year 2024

Based on Diseases segmentation, gastrointestinal was the leading Diseases in 2024

Based on Type segmentation, live biotherapeutic products (LBP) was the leading Type in 2024

On the basis of region, North America was the leading revenue generator in 2024

Human Microbiome Market- Segmentation Analysis:

The Global Human Microbiome Market is segmented on the basis of Product, Diseases, Type, Route of Administration, End-user, and Region.

The market is divided into four categories based on Product: prebiotics, probiotics, drugs, and sybnbiotics. The probiotics segment is anticipated to hold the largest market share in the global human microbiome market during the forecast period. This dominance is attributed to increasing consumer awareness of the benefits of probiotics for gut health, immunity, and overall wellness.

The market is divided into four categories based on Diseases: gastrointestinal diseases, infectious diseases, endocrine & metabolic disorders, and other diseases. Among these, the gastrointestinal diseases segment is anticipated to hold the largest market share in the market. This dominance is attributed to the high prevalence of gastrointestinal conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), celiac disease, and gastroesophageal reflux disease (GERD).

Human Microbiome Market- Geographical Insights

The North America region holds the largest share of the global human microbiome market. This dominance is attributed to a well-established healthcare infrastructure, significant investments in microbiome research, and a high prevalence of chronic diseases. Besides, the Asia-Pacific region is projected to experience the fastest growth in the human microbiome market during the forecast period. This rapid expansion is driven by increasing awareness of microbiome health, rising demand for personalized medicine, and advancements in sequencing technologies.

Human Microbiome Market- Competitive Landscape:

Rising interest in personalized medicine and microbiome-based therapies is driving intense competition among companies in this emerging field. Industry participants are focusing on strategic collaborations with research institutions and healthcare providers to accelerate product development. Many are investing heavily in R&D to discover novel microbiome-based diagnostics and therapeutics. Additionally, companies are securing patents and engaging in licensing agreements to strengthen their pipelines. Expansion into untapped regions and the development of consumer-targeted microbiome products also form key competitive strategies.

Recent Developments:

In February 2025, Seres Therapeutics launched SER-109, the first FDA-approved microbiome therapy in the U.S., designed to treat recurrent C. difficile infection by restoring gut microbiota using live bacterial spores.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN MICROBIOME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • ENTEROME
  • Pendulum
  • DuPont
  • Yakult U.S.A. Inc.
  • Metabiomics
  • Vedanta Biosciences, Inc.
  • Optibiotix Health plc
  • Microbiome Therapeutics Innovation Group
  • BioHM Health
  • Osel, Inc.
  • Seres Therapeutics
  • Infinant Health Inc.
  • Merck & Co., Inc.
  • Theriva Biologics
  • Qualigen Therapeutics, Inc.
  • Synlogic
  • Symbiotix, LLC
  • Resbiotic
  • Symberix, Inc.
  • Exegi Pharma Inc.
  • Seed Health Inc.
  • Biogaia AB
  • BiomeBank
  • Ferring Pharmaceuticals
  • Others

GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Prebiotics
  • Drugs
  • Synbiotics

GLOBAL HUMAN MICROBIOME MARKET, BY DISEASES- MARKET ANALYSIS, 2019 - 2032

  • Gastrointestinal Diseases
  • Infectious Diseases
  • Endocrine & Metabolic Disorders
  • Other Diseases

GLOBAL HUMAN MICROBIOME MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live Biotherapeutic Products (LBP)
  • Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
  • Other Microbiome Types

GLOBAL HUMAN MICROBIOME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Rectal
  • Oral

GLOBAL HUMAN MICROBIOME MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Long-term Care Facilities
  • Hospitals & Clinics
  • Others

GLOBAL HUMAN MICROBIOME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Microbiome Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Microbiome Market Snippet by Product
    • 2.1.2. Human Microbiome Market Snippet by Diseases
    • 2.1.3. Human Microbiome Market Snippet by Type
    • 2.1.4. Human Microbiome Market Snippet by Route of Administration
    • 2.1.5. Human Microbiome Market Snippet by End User
    • 2.1.6. Human Microbiome Market Snippet by Country
    • 2.1.7. Human Microbiome Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Microbiome Key Market Trends

  • 3.1. Human Microbiome Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Microbiome Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Microbiome Market Opportunities
  • 3.4. Human Microbiome Market Future Trends

4. Human Microbiome Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Microbiome Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Human Microbiome Market Landscape

  • 6.1. Human Microbiome Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Microbiome Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Probiotics
    • 7.1.3. Drugs
    • 7.1.4. Synbiotics

8. Human Microbiome Market - By Diseases

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diseases, 2024 & 2032 (%)
    • 8.1.2. Gastrointestinal Diseases
    • 8.1.3. Infectious Diseases
    • 8.1.4. Endocrine & Metabolic Disorders
    • 8.1.5. Other Diseases

9. Human Microbiome Market - By Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 9.1.2. Live Biotherapeutic Products (LBP)
    • 9.1.3. Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
    • 9.1.4. Other Microbiome Types

10. Human Microbiome Market - By Route of Administration

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 10.1.2. Rectal
    • 10.1.3. Oral

11. Human Microbiome Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Long-term Care Facilities
    • 11.1.3. Hospitals & Clinics
    • 11.1.4. Others

12. Human Microbiome Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Human Microbiome Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Human Microbiome Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Human Microbiome Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Human Microbiome Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Human Microbiome Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Human Microbiome Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. ENTEROME
    • 13.2.2. Pendulum
    • 13.2.3. DuPont
    • 13.2.4. Yakult U.S.A. Inc.
    • 13.2.5. Metabiomics
    • 13.2.6. Vedanta Biosciences, Inc.
    • 13.2.7. Optibiotix Health plc
    • 13.2.8. Microbiome Therapeutics Innovation Group
    • 13.2.9. BioHM Health
    • 13.2.10. Osel, Inc.
    • 13.2.11. Seres Therapeutics
    • 13.2.12. Infinant Health Inc.
    • 13.2.13. Merck & Co., Inc.
    • 13.2.14. Theriva Biologics
    • 13.2.15. Qualigen Therapeutics, Inc.
    • 13.2.16. Synlogic
    • 13.2.17. Symbiotix, LLC
    • 13.2.18. Resbiotic
    • 13.2.19. Symberix, Inc.
    • 13.2.20. Exegi Pharma Inc.
    • 13.2.21. Seed Health Inc.
    • 13.2.22. Biogaia AB
    • 13.2.23. BiomeBank
    • 13.2.24. Ferring Pharmaceuticals
    • 13.2.25. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us